| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | VP of Business Operations | Stock Options (Right to Buy) | 50,000 | $76,000 | $1.52 | 07 Jun 2023 | Direct |
| Bellerophon Therapeutics, Inc. | VP of Business Operations | Common Stock | 17,666 | $1,834 | $0.1038 | 09 Dec 2022 | Direct |
| Bellerophon Therapeutics, Inc. | VP of Business Operations | Restricted Stock Units | 25,500 | 09 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | VP of Business Operations | 09 Jun 2023, 16:11 |
| BLPH | Bellerophon Therapeutics, Inc. | 10 Feb 2023 | 1 | $76,000 | 4 | VP OF BUSINESS OPERATIONS | 14 Feb 2023, 15:47 |
| BLPH | Bellerophon Therapeutics, Inc. | 09 Dec 2022 | 3 | -$7,286 | 4 | VP OF BUSINESS OPERATIONS | 13 Dec 2022, 16:25 |
| BLPH | Bellerophon Therapeutics, Inc. | 26 Jan 2022 | 1 | $0 | 4 | VP OF BUSINESS OPERATIONS | 28 Jan 2022, 15:30 |